Novartis Reports Loss, Raises Forecasts After Clinical-Trial Setbacks
Novartis reported a loss due to clinical-trial setbacks and raised its forecasts.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.